A preclinical study reports a platform for the generation of dendritic cell-derived nanovesicles with enhanced immunostimulatory function, which demonstrate promising antitumoural activity in mouse models and might overcome some of the shortcomings of early-generation dendritic cell nanovaccines.
Corentin Jean Dominique Fivet, Pierluigi D'Acunto, Jonas Warmuth
Michel Bierlaire, Timothy Michael Hillel, Janody Pougala
Camille Sophie Brès, Anton Stroganov, Ozan Yakar, Marco Clementi, Christian André Clément Lafforgue, Anamika Nair Karunakaran